AAAAAA

   
Results: 1-10 |
Results: 10
HIGH-PURITY FACTOR-VIII CONCENTRATE IN THE TREATMENT OF VON-WILLEBRANDS-DISEASE
Authors: MANNUCCI PM CHEDIAK J BYRNES J KESSLER C MARCINIAK E HANNA W RETZIOS AD
Citation: Pm. Mannucci et al., HIGH-PURITY FACTOR-VIII CONCENTRATE IN THE TREATMENT OF VON-WILLEBRANDS-DISEASE, Thrombosis and haemostasis, 1997, pp. 2102-2102
NO PROZAC NATION
Authors: LUCAS J BYRNES J ELLIS M MITCHELL J GREENBERG J
Citation: J. Lucas et al., NO PROZAC NATION, Fortune, 136(1), 1997, pp. 20-20
A HIGH-PURITY FACTOR-VIII CONCENTRATE IN THE TREATMENT OF VON-WILLEBRANDS-DISEASE
Authors: MANNUCCI PM CHEDIAK J BYRNES J KESSLER C MARCINIAK E HANNA W RETZIOS AD
Citation: Pm. Mannucci et al., A HIGH-PURITY FACTOR-VIII CONCENTRATE IN THE TREATMENT OF VON-WILLEBRANDS-DISEASE, Blood, 90(10), 1997, pp. 133-133
DIFFERENTIAL FLOW BETWEEN SOLAR-WIND PROTONS AND ALPHA-PARTICLES - FIRST WIND OBSERVATIONS
Authors: STEINBERG JT LAZARUS AJ OGILVIE KW LEPPING R BYRNES J
Citation: Jt. Steinberg et al., DIFFERENTIAL FLOW BETWEEN SOLAR-WIND PROTONS AND ALPHA-PARTICLES - FIRST WIND OBSERVATIONS, Geophysical research letters, 23(10), 1996, pp. 1183-1186
A HIGH-PURITY FACTOR-VIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRANDS DISEASE
Authors: MANNUCCI PM CHEDIAK J BYRNES J KESSLER C MARCINIAK E HANNA W RETZIOS AD
Citation: Pm. Mannucci et al., A HIGH-PURITY FACTOR-VIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRANDS DISEASE, Blood, 88(10), 1996, pp. 1309-1309
CORRECTION OF LABORATORY MEASUREMENTS OF VON-WILLEBRANDS DISEASE BY AHIGH-PURITY FACTOR-VIII CONCENTRATE
Authors: MANNUCCI PM CHEDIAK J BYRNES J KESSLER C MARCINIAK E RETZIOS AD
Citation: Pm. Mannucci et al., CORRECTION OF LABORATORY MEASUREMENTS OF VON-WILLEBRANDS DISEASE BY AHIGH-PURITY FACTOR-VIII CONCENTRATE, Thrombosis and haemostasis, 73(6), 1995, pp. 1173-1173
DIFFERENTIAL TRANSCRIPTION EFFICIENCY OF 2 IG V-H PROMOTERS IN-VITRO
Authors: BUCHANAN KL HODGETTS SI BYRNES J WEBB CF
Citation: Kl. Buchanan et al., DIFFERENTIAL TRANSCRIPTION EFFICIENCY OF 2 IG V-H PROMOTERS IN-VITRO, The Journal of immunology, 155(9), 1995, pp. 4270-4277
A HIGH-PURITY FACTOR-VIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRANDS DISEASE
Authors: MANNUCCI PM CHEDIAK J BYRNES J KESSLER C MARCINIAK E RETZIOS AD
Citation: Pm. Mannucci et al., A HIGH-PURITY FACTOR-VIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRANDS DISEASE, Blood, 86(10), 1995, pp. 756-756
HEPATITIS-C VIRUS-RELATED APLASTIC-ANEMIA
Authors: BANKS AT PIATICK M JEFFERS LJ BERNSTEIN DE SCHIFF ER KIM J BYRNES J
Citation: At. Banks et al., HEPATITIS-C VIRUS-RELATED APLASTIC-ANEMIA, Blood, 86(10), 1995, pp. 1904-1904
BASE-LINE CD8 COUNTS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH HIV-ASSOCIATED LYMPHOMAS UNDERGOING CHEMOTHERAPY
Authors: HARRINGTON W PATARCA R BYRNES J CABRAL L LAI S VENET T COHEN J KLIMAS NG FLETCHER MA
Citation: W. Harrington et al., BASE-LINE CD8 COUNTS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH HIV-ASSOCIATED LYMPHOMAS UNDERGOING CHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000566-10000566
Risultati: 1-10 |